SNGSynairgenSNG info
$0.05info10.15%24h
Global rank
Market cap$10.38M
Change 7d-1.79%
YTD Performance-28.39%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Synairgen (SNG) Stock Overview

    Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease. The company was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

    SNG Stock Information

    Symbol
    SNG
    Address
    Mailpoint 810Southampton, SO16 6YDUnited Kingdom
    Founded
    -
    Trading hours
    8:00 AM - 4:30 PM GMT
    Website
    https://www.synairgen.com
    Country
    🇬🇧 United Kingdom
    Phone Number
    44 23 8051 2800

    Synairgen (SNG) Price Chart

    -
    Value:-

    Synairgen Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.05155283513223358
    N/A
    Market Cap
    $10.38M
    N/A
    Shares Outstanding
    201.38M
    N/A
    Employees
    30.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org